C.H. Robinson Increases Quarterly Cash Dividend
Get Alerts CHRW Hot Sheet
Join SI Premium – FREE
MINNEAPOLIS--(BUSINESS WIRE)-- C.H. Robinson Worldwide, Inc. (“C.H. Robinson”) (Nasdaq: CHRW) announced that its Board of Directors today declared an increase to its regular quarterly cash dividend to 51 cents ($0.51) per share from 50 cents ($0.50) per share, payable on December 31, 2019, to shareholders of record on December 16, 2019.
C.H. Robinson has distributed regular dividends for more than twenty-five years. As of December 5, 2019, there were approximately 135,002,925 shares outstanding.
About C.H. Robinson
C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With over $20 billion in freight under management and 18 million shipments annually, we are the world’s largest logistics platform. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the world’s economy. With the combination of our multimodal transportation management system and expertise, we use our information advantage to deliver smarter solutions for our more than 124,000 customers and 76,000 contract carriers. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers’ businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit us at www.chrobinson.com (Nasdaq: CHRW).
Source: C.H. Robinson
CHRW-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20191205005887/en/
Robert Houghton, Vice President of Investor Relations and Treasury
Email: [email protected]
Adrienne Brausen, Investor Relations
Email: [email protected]
Source: C.H. Robinson Worldwide, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- C.H. Robinson Worldwide (CHRW) PT Lowered to $198 at Stifel
- Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System
- C.H. Robinson Worldwide (CHRW) PT Lowered to $175 at Baird
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share